1 |
Meretoja A, Keshtkaran M, Saver JL, et al.Stroke thrombolysis: save a minute, save a day | NOVA.The university of newcastle's digital repository[J]. Stroke, 2014, 45(4): 1053-1058.
|
2 |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
|
3 |
Khandelwal P, Yavagal DR, Sacco RL, et al.Acute ischemic stroke intervention[J]. J Am Coll Cardiol, 2016 67(22): 2631-2644.
|
4 |
Qin B, Zhao MJ, Chen H, et al.Real-world outcomes of acute ischemic stroke treatment with intravenous thrombolysis: a systematic review and meta-analysis[J]. J Stroke Cerebrovasc Dis, 2018, 27(12): 3542-3548.
|
5 |
Cheng JW, Zhang XJ, Cheng LS, et al.Low-dose tissue plasminogen activator in acute ischemic stroke: a systematic review and meta-analysis[J]. J Stroke Cerebrovasc Dis, 2018, 27(2): 381-390.
|
6 |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组[J].中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-678.
|
7 |
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333(24): 1581-1587.
|
8 |
Hacke W, Kaste M, Fieschi C, et al.Intravenous thrombolysis with ecombinant tissue plasminogen acti-vator for acute hemispheric stroke[J]. JAMA, 1995, 274(13): 1017-1025.
|
9 |
Hacke W, Kaste M, Fieschi C, et al.Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASS II). second european-Australasian acute stroke study investigators[J]. Lancet, 1998, 352(9136): 1245-1251.
|
10 |
Hacke W, Kaste M, Fieschi C, et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2008, 359(13): 1317-1329.
|
11 |
国家"九五"公关课题些协作组.急性脑梗死(6h以内)静脉溶栓治疗[J].中风与神经疾病杂志,2001,18(5):259-261.
|
12 |
国家"九五"公关课题些协作组.急性脑梗死六小时以内的静脉溶栓治疗[J].中华神经科杂志,2002,35(4):210-213.
|
13 |
Thomalla G, Simonsen CZ, Boutitie F, et al.MRI-guide thrombolysis for stroke with unkown time of onset[J]. N EnglJ Med, 2018, 379(7): 611-622.
|
14 |
Lees KR, Emberson J, Blackwell L, et al.Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials[J]. Stroke, 2016, 47(9): 2373-2379.
|
15 |
Furlan A, Higashida R, Wechsler L, et al.Intra-arterial prourokinase for acute ischemic stroke.The PROACT M study: a randomized controlled trial.Prolyse in acute cerebralthromboembolism[J]. JAMA, 1999, 282(21): 2003-2011.
|
16 |
Macleod MR, Davis SM, Mitchell PJ, et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke[J]. Cerebrovasc Dis, 2005, 20(1): 12-17.
|
17 |
Lindsberg PJ, Mattle HP.Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis[J]. Stroke, 2006, 37(3): 922-928.
|
18 |
中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组.急性缺血性卒中血管内治疗中国指南2018[J].中国卒中杂志,2018,10(7):706-729.
|
19 |
Lewandowski CA, Frankel M, Tomsick TA, et al.Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke(EMS) Bridging Trial[J]. Stroke, 1999, 30(12): 2598-2605.
|
20 |
IMS Study Investigators.Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study[J]. Stroke, 2004, 35(4): 904-911.
|
21 |
姜长春,李月春,王宝军,等.动脉溶栓和动静脉联合溶栓及机械取栓治疗急性脑梗死的比较研究[J].中华老年心血管病杂志,2013,1(15):60-63.
|
22 |
段振晖,朱武生.静脉溶栓桥接治疗急性缺血性卒中[J].国际脑血管病杂志,2017,2(25):155-158.
|
23 |
Mistry EA, Mistry AM, Nakawah MO, et al.Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients: a meta-analysis[J]. Stroke, 2017, 48(9): 2450-2456.
|
24 |
Bellwald S, Weber R, Dobrocky T, et al.Direct mechanical intervention versus bridging therapy in stroke patients eligible for intravenous thrombolysis: a pooled analysis of 2 registriesl[J]. Stroke, 2017, 48(12): 3282-3288.
|
25 |
中国脑血管病杂志编辑部.急性卒中患者血管内治疗前行静脉内重组组织型纤溶酶原激活剂桥接治疗对神经功能改善的作用[J].中国脑血管病杂志,2017,14(3):163.
|
26 |
Guedin P, Larcher A, Decroix JP, et al.Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic strokel[J]. J Stroke Cerebrovasc Dis, 2015, 24(5): 952-957.
|
27 |
Chandra RV, Leslie-mazwi TM, Mehta BP, et al.Does the use of IV tPA in the current era of rapid and predictable recanalization by mechanical embolectomy represent good value?[J]. J Neurointerv Surg, 2016, 8(5): 443-446.
|
28 |
Badhiwala JH, nassiri F, Alhazzani W, et al.Endovascular Thrombectomy for acute ischemic stroke: a meta-analysis[J]. JAMA, 2015, 314(17): 1832-1843.
|
29 |
张磊,李子付,邢鹏飞,等.桥接治疗和直接血管内治疗对急性大血管闭塞性卒中的疗效对比分析[J].中华神经外科杂志,2018,3(34):221-225.
|
30 |
Goyal M, Menon BK, van Zwam WH, et al.Endovascular thrombectomy after-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016, 387(10029): 1723-1731.
|
31 |
Coutinho JM, Liebeskind DS, Slater LA, et al.Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke: a pooled analysis of the SWIFT and STAR Studies[J]. JAMA Neurol, 2017, 74(3): 268-274.
|
32 |
Coutinho JM, Liebeskind DS, Slater LA, et al.Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke: a pooled analysis of the SWIFT and STAR studies[J]. JAMA Neurol, 2017, 74(3): 268-274.
|
33 |
Jovin TG, Saver JL, Ribo M, et al.Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods[J]. Stroke, 2017, 12(6): 641-652.
|
34 |
Berkhemer OA, Fransen PS, Beumer D, et al.A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1): 11-20.
|
35 |
Kabbasch C, Hlenbruch M, Stampfl S, et al.First-line lesional aspiration in acute stroke thrombectomy using a novel intermediate catheter: Initial experiences with the SOFIA[J]. Interv Neuradiol, 2016, 22(3): 333-339.
|
36 |
王玉,魏玉清,孔咏梅,等.机械碎栓联合动静脉溶栓术治疗急性血栓性椎一基底动脉闭塞的疗效及安全性[J].山东医药,2016,56(23):93-94.
|
37 |
Zaidat OO, Mueller-Kronast NH, Hassan AE, et al.Impact of balloon guide catheter use on clinical and angiographic outcomes in the STRATIS stroke thrombectomy registry[J]. Stroke, 2019, 50(3): 697-704.
|
38 |
Malke H, Ferretti JJ.Streptokinase: cloning, expression, and excretion by Escherichia coli[J]. Proc Natl Acad Sci USA, 1984, 81(11): 3557-3561.
|
39 |
Multicentre Acute stroke Trial: Italy(MAST-I)Group.Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke[J]. Lancet, 1995, 346: 1509-1514.
|
40 |
MacFarlane RG, Pilling J. Fibrinolytic activity of normal urine[J]. Nature, 1947, 159(4049): 779.
|
41 |
Williams JRB.The fibrinolytic activity of urine[J]. Br J Exp Pathol, 1951, 32(6): 530-537.
|
42 |
刘芳.急性脑梗塞静脉溶栓治疗的研究进展[J].现代诊断与治疗,2018,29(15):2362-2364.
|
43 |
Collen D, Lijnen HR.Tissue-type plasminogen activator: a historical perspective and personal account[J]. J Thromb Haemost, 2004, 2(4): 541-546.
|
44 |
Katzan IL, Hammer MD, Hixson ED, et al.Utilization of intravenous tissue plasminogen activator for acute ischemic stroke[J]. Arch Neurol, 2004, 61(3): 346-350.
|
45 |
Jauch EC, Saver JL, Adams HP, et al.Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013, 44(3): 870-947.
|
46 |
Berkowitz SD, Granger CB, Pieper KS, et al.Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction.The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries(GUSTO) i investigators[J]. Circulation, 1997, 95(11): 2508-2516.
|
47 |
Li X, Ling L, Li C, et al.Efficacy and safety of desmoteplase in acute ischemic stroke patients: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2017, 96(18): e6667.
|
48 |
Chester KW, Corrigan M, Schoeffler JM, et al.Making a case for the right'-ase’ in acute ischemic stroke: alteplase, tenecteplase, and reteplase[J]. Expert Opin Drug Saf, 2019, 18(2): 87-96.
|
49 |
Powers WJ, Rabinstein AA, Ackerson T, et al.2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2018, 49(3): e46-110.
|
50 |
Haley EC Jr, Lyden PD, Johnston KC, et al.A pilot dose escalation safety study of tenecteplase in acute ischemic stroke[J]. Stroke, 2005, 36(3): 607-612.
|
51 |
Ramakrishnan TCR, Kumaravelu S, Narayan SK, et al.Efficacy and safety of intravenous tenecteplase bolus in acute ischemic stroke: results of two open-label, multicenter trials[J]. Am J Cardiovasc Drugs, 2018, 18(5): 387-395.
|
52 |
Logallo N, Novotny V, Assmus J, et al.Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial[J]. Lancet Neurol, 2017, 16(10): 781-788.
|
53 |
Liebeskind DS, Sanossian N. How well do blood flow imaging and collaterals on angiography predict brain at risk?[J]. Nurology, 2012, 79(13 Suppl 1): S105-S109.
|
54 |
Nicola L, Christopher E K, Aliona N, et al.The norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trlal ot tenecteplase vs.alteplase in acute ischaemic stroke[J]. BMC Neurology, 2014, 14(1): 106-113.
|
55 |
Rana PB, Jacob NT, Toms T, et al.Comment on: "Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials" [J]. Am J Cardiovasc Drugs, 2019, 19(2): 219-221.
|